Supplementary Figure 3 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1 Lauren A. Byers , Jing Wang , Monique B. Nilsson , Junya Fujimoto , Pierre Saintigny , John S. Yordy , Uma Giri , Michael Peyton , You Hong Fan , Lixia Diao , Fatemeh Masrorpour , Li Shen , Wenbin Liu , Boris Duchemann , Praveen K. Tumula , Vikas Bhardwaj , James Welsh , Stephanie Weber , Bonnie S. Glisson , Neda Kalhor , Ignacio I. Wistuba , Luc Girard , Scott M. Lippman , Gordon B. Mills , Kevin R. Coombes , John N. Weinstein , John D. Minna , John V. Heymach openalex（2023）
摘要
PDF file, 81K, Effect of PARP inhibition in combination with standard chemotherapy.
更多 查看译文
关键词
parp1, small cell lung cancer, therapeutic targets
AI 理解论文
溯源树
样例
